enzyme preparation, method for producing a pancreatin product, pharmaceutical composition and method for treating exocrine pancreatic insufficiency
WO2014068018A1
Methods of prognosis and diagnosis of sepsis
AU2013228033A1
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
AU2013202866A1
Methods for treating psoriasis
AU2013202845A1
Powdered protein compositions and methods of making same
US2013116241A1
Novel inhibitor compounds of phosphodiesterase type 10a
AU2012201856A1
Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
WO2012085236A1
Solid retard formulations based on solid dispersions
WO2012061779A1
Drug formulations
WO2012059432A1
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
US2012040969A1
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
WO2012059431A1
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
BR112013008737A2
Curcuminoid Solid Dispersion Formulation
BR112013010524A2
melt extruded solid dispersions containing an apoptosis inducing agent
EP2621914A1
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP2572731A1
Formulations based on solid dispersions
CA2806816A1
Method for detection of ischemic strokes
WO2011151418A2
Nanosuspension formulation comprising a polydimethylsiloxane hydrophobic phase
EP2547998A1
Method and device for determining mechanical stress load and interface effects on particles dispersed in a fluid
WO2011101352A2
Test solvent for evaluating the compatibility of biologically active substances and graft copolymers
